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Epidemiology is the study of disease frequencies and the
causes of diseases in human populations. Terminology
from this field of study is frequently encountered in the
sports medicine literature, particularly with regard to
causes of injuries to athletes and the prevention of such
injuries. Suppose you are a team physician for a profes-
sional football team and you noted that a relatively high
number of athletes had tears of the PCL. How common is
this problem? Two epidemiologic measures may be helpful
in understanding this problem.
MEASURES OF DISEASE FREQUENCY
Prevalence is the number of existing cases of a disease or
injury divided by the total population at risk at a given
point in time. For example, suppose an NFL team physi-
cian conducting preseason examinations of a team found 2
PCL tears in 100 athletes. In this example, the population
is established at a specific point in time, and the preva-
lence of PCL tears for this team before the season starts is
2%.
Incidence, on the other hand, refers to the number of
new cases that develop over a specified period of time.
There are two ways to look at incidence: the cumulative
incidence and the incidence rate. The cumulative inci-
dence is the number of new cases of a disease during a
given duration of time divided by the total cases without
the disease at the start of the time period, but who are at
risk. In the example of a football team with 100 players, 2
had PCL tears before the season started. At the end of the
season the physician reexamined the team and found a
total of 6 players with PCL tears. Among the 98 players
who were healthy at the beginning of the season, 4 new
PCL tears occurred during the season, and thus the cu-
mulative incidence for the team during the season was 4 of
98 or 4.1%, while the prevalence at the beginning of the
season was 2 of 100 or 2%, and at the end of the season the
prevalence was 6 of 100 or 6% (Table 1).
Unfortunately, the cumulative incidence does not ac-
count for varying time periods that players may be ex-
posed to injury and, therefore, may not be a precise
method for estimating the injury rate. Continuing with
the PCL example, suppose most injuries to the PCL occur
during games. During the season, football players may be
traded or activated from the injured reserve list, or they
may be reserves and not play in games. These players
would not have had the exposure to as many injury-pro-
ducing events (games) as players who had played all sea-
son. The incidence rate provides a more precise estimate of
the impact of exposure; it is the number of new cases that
develop during a given time period divided by the total
person-time of observation. The total person-time of ob-
servation is calculated by adding together all of the time of
exposure that each player has endured; in this example, it
is the amount of playing time for each player. The inci-
dence rate not only includes the population at risk, but
also accounts for each participant’s time at risk.
For example, for a football team of 100 players, the risk
of PCL injuries during game playing in the 98 players
with intact ligaments at the start of the season is deter-
mined by documenting the total minutes of time played in
a game for each player and whether a PCL injury oc-
curred. The game time played for each player is added to
obtain the total time at risk. To determine the incidence
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TABLE 1
Example of Prevalence, Incidence, and Relative Risk
rate, the number of new cases of PCL injury is divided by
the total person-time of playing (Table 2).
MEASURES OF DISEASE ASSOCIATION
A relationship often exists between the exposure to a
particular risk factor and the development of a disease or
injury. Football players who play frequently are more
likely to get injured. One way of expressing this relation-
ship is the relative risk. The relative risk is an estimate of
the magnitude of the association between the exposure to
a risk factor and an injury, and indicates the likelihood of
developing the injury in the exposed group relative to the
group that has not been exposed. It is the incidence of
the injury in the exposed group divided by the incidence in
the unexposed group. In the football team example, an
incidence of 4.1% for PCL tears was found during the last
season (Table 1). To assess the risk that playing in football
games has on the development of PCL tears, the incidence
of PCL tears in an unexposed group (the reserve players
TABLE 2
Example of Incidence Rate’
a In this hypothetical example 10 new players are followed over
a season and the number of minutes of game time played as well
as the development of a PCL tear is assessed. The incidence rate
of 2 PCL injuries per 10,000 minutes of playing time assesses the
risk of sustaining a PCL injury during play.
who practice but do not play in games) could be compared
with the incidence of PCL tears in the exposed group
(those players who start or play in games). For example,
suppose only 1 PCL tear was noted in 50 reserves during
the course of the season, producing an incidence of 2%
(Table 1). On the other hand, among the 48 healthy start-
ing players, 3 new PCL tears developed during the season,
producing an incidence for starters of 6.25%. Dividing the
incidence of those exposed to the risk of playing games
(6.25%) by the incidence of those not exposed to games
(2%) gives us the relative risk of a football player injuring
his PCL by playing a season of football games, which is
3.125.
A relative risk of 1.0 means that the incidence rate of a
disease or injury in the exposed group is identical to the
incidence rate of the unexposed group, indicating there is
no association observed between the exposure to a risk
factor and the development of a disease. When the relative
risk is greater than 1.0, a positive association exists be-
tween the exposure to a risk factor and a disease. In this
example, the football players who play in games have
3.125 times the risk of developing a PCL tear compared
with reserves. If the relative risk is less than 1.0, an
inverse association exists, such that exposure to a partic-
ular variable has a protective effect and decreases the risk
of disease or injury to those exposed.
Cohort studies are particularly useful for estimating
relative risk. In a cohort study, a group of participants
who are disease- or injury-free is observed over time pro-
spectively with exposures and the onset of the disease or
injury documented as they occur. Many studies, however,
are case-control studies in which the participants are se-
lected on the basis of their disease status, and their his-
tories are evaluated retrospectively to identify exposures
and risks preceding the disease or injury. The case-control
study, which by definition begins with a population of
diseased or injured participants, cannot be evaluated pro-
spectively to determine exposure risks, and as such the
relative risk calculation cannot be used. Instead, the rel-
ative risk can be approximated by determining the odds
ratio. The odds ratio is the odds of exposure in those with
the disease or injury compared with the odds of exposure
in those without the disease or injury. These probabilities
can be reduced to a simple formula useful for calculating
the odds ratio (Table 3).
For example, suppose the team physician is asked to
evaluate 100 potential new players for the team. The top
100 potential new players fall into two major groups: there
are 20 players with PCL injuries and 80 with intact liga-
ments (Table 3). Of the 20 players with PCL injuries, 15
were starters and played in games during their college
seasons and 5 were reserves and did not play. Of the 80
players with intact PCLs, 50 were reserves and 30 were
starters who played in games. The odds ratio is calculated
and is found to be 5.0 (Table 3). Thus, the odds ratio takes
retrospective data and determines the odds of the expo-
sure, given that the player had the injury. In this case, the
football player has a 5-fold greater chance of having an




Example of Determining Odds Ratio
a = numbers of players who are exposed and have the condition or disease
b = number of players who are exposed and do not have the condition or disease
c = number of players who are not exposed and have the condition or disease
d = number of players who are not exposed and do not have the condition or disease
It is important to understand that relative risks and
odds ratios should be accompanied by confidence inter-
vals. The confidence interval provides us with an estimate
of the degree of assurance as to the range within which the
true relative risk or odds ratio lies. The confidence inter-
val guides us in our interpretation of the study findings.
Confidence intervals will be covered in more detail in a
future &dquo;Current Concepts&dquo; article.
It also is important to understand that because there is
an association between the risk factor being studied and
the injury or disease that occurs, it is not necessarily true
that the risk factor causes the injury or disease. It is
possible that the association demonstrated by the relative
risk or odds ratio may be due, totally or in part, to bias,
confounding, or chance.
Measures of disease frequency such as prevalence and
incidence and measures of association such as relative
risk and odds ratios are basic tools that help us to quantify
the relationship between exposures to risk factors and
diseases or injuries. The data provided by these tools
provide the foundation from which researchers can formu-
late testable hypotheses for further study.
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